Ji-chun G. Ma

1Department Of Hematology, 8 Dianli Rd
Zhenjiang, 212002, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 95 publications

Expression and Clinical Significance of lncRNA NCK1-AS1 in Acute Myeloid Leukemia

Expression and Clinical Significance of lncRNA NCK1-AS1 in Acute Myeloid Leukemia

Journal: Zhongguo shi yan xue ye xue za zhi

Published: May 06, 2025

Bioinformatic characterization of STING expression in hematological malignancies reveals association with prognosis and anti-tumor immunity.

Bioinformatic characterization of STING expression in hematological malignancies reveals association with prognosis and anti-tumor immunity.

Journal: Frontiers in immunology

Published: August 07, 2024

Detection of NPM1 Mutations in Acute Myeloid Leukemia by using Drop-Off Droplet Digital PCR and its Clinical Application.

Detection of NPM1 Mutations in Acute Myeloid Leukemia by using Drop-Off Droplet Digital PCR and its Clinical Application.

Journal: Clinical laboratory

Published: November 10, 2023

Identification and validation of necroptosis-related gene signatures to predict clinical outcomes and therapeutic responses in acute myeloid leukemia.

Identification and validation of necroptosis-related gene signatures to predict clinical outcomes and therapeutic responses in acute myeloid leukemia.

Journal: Aging

Published: May 15, 2023

SLIT2 promoter hypermethylation predicts disease progression in chronic myeloid leukemia.

SLIT2 promoter hypermethylation predicts disease progression in chronic myeloid leukemia.

Journal: European journal of medical research

Published: August 04, 2022

Clinical Significance of Low Expression of LncRNA CASC15 in Acute Myeloid Leukemia with NPM1 Mutations

Clinical Significance of Low Expression of LncRNA CASC15 in Acute Myeloid Leukemia with NPM1 Mutations

Journal: Zhongguo shi yan xue ye xue za zhi

Published: June 10, 2022

m6A regulator-based methylation modification patterns and characterization of tumor microenvironment in acute myeloid leukemia.

m6A regulator-based methylation modification patterns and characterization of tumor microenvironment in acute myeloid leukemia.

Journal: Frontiers in genetics

Published: May 20, 2022

DNA methylation-mediated differential expression of DLX4 isoforms has opposing roles in leukemogenesis.

DNA methylation-mediated differential expression of DLX4 isoforms has opposing roles in leukemogenesis.

Journal: Cellular & molecular biology letters

Published: April 18, 2022

SLIT2 promoter hypermethylation-mediated SLIT2-IT1/miR-218 repression drives leukemogenesis and predicts adverse prognosis in myelodysplastic neoplasm.

SLIT2 promoter hypermethylation-mediated SLIT2-IT1/miR-218 repression drives leukemogenesis and predicts adverse prognosis in myelodysplastic neoplasm.

Journal: Leukemia

Published: March 17, 2022

Whole-Genome DNA Methylation Sequencing Reveals Epigenetic Changes in Myelodysplastic Syndromes.

Whole-Genome DNA Methylation Sequencing Reveals Epigenetic Changes in Myelodysplastic Syndromes.

Journal: Frontiers in oncology

Published: March 16, 2022

Pan-cancer analysis reveals distinct clinical, genomic, and immunological features of the LILRB immune checkpoint family in acute myeloid leukemia.

Pan-cancer analysis reveals distinct clinical, genomic, and immunological features of the LILRB immune checkpoint family in acute myeloid leukemia.

Journal: Molecular therapy oncolytics

Published: December 21, 2021

Pan-cancer analysis identifies CD300 molecules as potential immune regulators and promising therapeutic targets in acute myeloid leukemia.

Pan-cancer analysis identifies CD300 molecules as potential immune regulators and promising therapeutic targets in acute myeloid leukemia.

Journal: Cancer medicine

Published: November 04, 2021

Showing 1-12 of 95

Last Updated: 09/26/2026